GMED Globus Medical Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 99
Relative Strength: Rel. Strength: 52
Relative Valuation: Rel. Valuation: 81
Relative Profitability: Rel. Profitability: 94

EPS in 2026 (TTM): $4.35

Last Report Period Date: Mar 31, 2026

As of June 2026, according to Globus Medical's current financial statements, the company's 12-month EPS is $4.35. For the year 2025, the company recorded an earnings per share (EPS) of $3.98, which marks an increase compared to its EPS of $0.76 in 2024. Globus Medical's earnings per share for the quarterly report ending on Mar 31, 2026 reached $0.92.

GMED earnings history

Historical annual and quarterly earnings per share (EPS) data for Globus Medical
EPS (TTM)
$4.35
EPS Growth YoY (Quarterly)
67.3%
EPS (Quarterly)
$0.92
EPS Growth (Quarterly)
-12.4%

The annual EPS for the year 2025 was $3.98, an increase of 423.7% from $0.76 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $0.92, showing a 67.3% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is $4.35. For the year 2024, the yearly earnings per share was $0.76, marking a decrease of 30.3% from 2023.

GMED earnings chart

GMED EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
67.3%
EPS growth YoY
423.7%
EPS growth 3Y avg
28.2%
EPS growth 5Y avg
30.8%

Globus Medical has registered an increase in EPS of 67.3% during the last 12 months (YoY, quarterly). In the last three years, GMED recorded an average annual EPS growth rate of 28.2%. Globus Medical had an average annual EPS growth rate of 30.8% during the last 5 years. Across the last decade, GMED had an average annual EPS growth of 12.8%.

GMED Earnings Waterfall

Breakdown of revenue, profit and net income for Globus Medical

GMED Earnings vs Peers

What are the earnings of GMED compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
GMED Globus Medical Inc 18.35 423.7% 28.2% 30.8%
SYK Stryker Corp 35.42 8% 10.9% 14.8%
OFIX Orthofix Medical Inc N/A 29.4% N/A N/A
ATEC Alphatec Holdings Inc N/A 15% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.